🇺🇸 FDA
Patent

US 9320796

Methods and compositions for self-regulated release of active pharmaceutical ingredient

granted A61KA61K31/5517A61K47/02

Quick answer

US patent 9320796 (Methods and compositions for self-regulated release of active pharmaceutical ingredient) held by Acurx Pharmaceuticals, Inc. expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Acurx Pharmaceuticals, Inc.
Grant date
Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/5517, A61K47/02, A61K47/32, A61K9/2009